South & Central America Immunodiagnostics Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 South & Central America Immunodiagnostics Market – by Product

1.3.2 South & Central America Immunodiagnostics Market – by Clinical Indication

1.3.3 South & Central America Immunodiagnostics Market – by End User

1.3.4 South & Central America Immunodiagnostics Market – by Country

2. South & Central America Immunodiagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Immunodiagnostics Market – Market Landscape

4.1 Overview

4.2 South & Central America PEST Analysis

4.3 Expert’s Opinion

5. South & Central America Immunodiagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Infectious Diseases

5.1.2 Growing Use of Point-of-Care Immunodiagnostics

5.2 Market Restraints

5.2.1 Inadequate Reimbursement Scenario

5.3 Market Opportunities

5.3.1 Rising Focus on R&D Investment and Expansion by Key Players

5.4 Future Trends

5.4.1 Technological Advancements in Immunodiagnostics

5.5 Impact Analysis

6. Immunodiagnostics Market – South & Central America Analysis

6.1 South & Central America Immunodiagnostics Market Revenue Forecast and Analysis

7. South & Central America Immunodiagnostics Market Analysis – by Product

7.1 Overview

7.2 South & Central America Immunodiagnostics Market, By Product, 2022 & 2030 (%)

7.3 Enzyme-linked Immunosorbent Assays (ELISA)

7.3.1 Overview

7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4 Chemiluminescence Immunoassays (CLIA)

7.4.1 Overview

7.4.2 Chemiluminescence Immunoassays (CLIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.3 Vitamin D Assay

7.4.3.1 Overview

7.4.3.2 Vitamin D Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.4 HIV Detection

7.4.4.1 Overview

7.4.4.2 HIV Detection: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.5 HIV Ag/Ab Combo assay

7.4.5.1 Overview

7.4.5.2 HIV Ag/Ab Combo Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.6 Other Tests

7.4.6.1 Overview

7.4.6.2 Other Tests: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.5 Radioimmunoassays (RIA)

7.5.1 Overview

7.5.2 Radioimmunoassays (RIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Immunodiagnostics Market Analysis – Clinical Indication

8.1 Overview

8.2 South & Central America Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)

8.3 Infectious Diseases:

8.3.1 Overview

8.3.2 Infectious Diseases: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.1 COVID-19

8.3.2.1.1 Overview

8.3.2.1.2 COVID-19: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.2 Tuberculosis

8.3.2.2.1 Overview

8.3.2.2.2 Tuberculosis: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.3 Lyme

8.3.2.3.1 Overview

8.3.2.3.2 Lyme: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.4 Infection Management

8.3.2.4.1 Overview

8.3.2.4.2 Infection Management: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.5 Zika

8.3.2.5.1 Overview

8.3.2.5.2 Zika: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.6 Treponema

8.3.2.6.1 Overview

8.3.2.6.2 Treponema: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.7 TORCH

8.3.2.7.1 Overview

8.3.2.7.2 TORCH: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.8 Measles and Mumps

8.3.2.8.1 Overview

8.3.2.8.2 Measles and Mumps: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.9 VZV

8.3.2.9.1 Overview

8.3.2.9.2 VZV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.10 EBV

8.3.2.10.1 Overview

8.3.2.10.2 EBV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.4 Hepatitis+HIV:

8.4.1 Overview

8.4.2 Hepatitis+HIV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.5 Gastrointestinal

8.5.1 Overview

8.5.2 Gastrointestinal: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.6 Metabolic Disorders

8.6.1 Overview

8.6.2 Metabolics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7 Endocrinology

8.7.1 Overview

8.7.2 Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.3 Hypertension

8.7.3.1 Overview

8.7.3.2 Hypertension: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.4 Growth

8.7.4.1 Overview

8.7.4.2 Growth: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.5 Diabetes

8.7.5.1 Overview

8.7.5.2 Diabetes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.6 Thyroid

8.7.6.1 Overview

8.7.6.2 Thyroid: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.7 Reproductive Endocrinology

8.7.7.1 Overview

8.7.7.2 Reproductive Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Immunodiagnostics Market Analysis – End User

9.1 Overview

9.2 South & Central America Immunodiagnostics Market Share by End User - 2022 & 2030 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.5 Diagnostic Laboratories

9.5.1 Overview

9.5.2 Diagnostic Laboratories: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.6 Academic and Research Institutes

9.6.1 Overview

9.6.2 Academic and Research Institutes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Immunodiagnostics Market – Revenue and Forecast to 2030 – Country Analysis

10.1 Overview

10.1.1.1 Brazil: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Brazil: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3 Brazil: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.1.3.1 Brazil: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4 Brazil: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4.1 Brazil: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4.2 Brazil: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.5 Brazil: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.2 Argentina: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Argentina: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 Argentina: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.2.3.1 Argentina: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4 Argentina: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4.1 Argentina: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4.2 Argentina: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.5 Argentina: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.3 Rest of South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 Rest of South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 Rest of South & Central America: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.3.3.1 Rest of South & Central America: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4 Rest of South & Central America: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4.1 Rest of South & Central America: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4.2 Rest of South & Central America: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.5 Rest of South & Central America: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

11. South & Central America Immunodiagnostics Market –Industry Landscape

11.1 Overview

11.2 Growth Strategies in the South & Central America immunodiagnostics market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Abbott Laboratories

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F. Hoffmann-La Roche Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 DiaSorin SpA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Danaher Corp

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Thermo Fisher Scientific Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 PerkinElmer Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 bioMerieux SA

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Svar Life Science AB

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Siemens Healthcare GmbH

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. Brazil Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 2. Brazil Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 3. Brazil Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 4. Brazil Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 5. Brazil Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 6. Brazil Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 7. Argentina Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 8. Argentina Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 9. Argentina Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 10. Argentina: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 11. Argentina Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 12. Argentina Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 13. Rest of South & Central America Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 14. Rest of South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 15. Rest of South & Central America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 16. Rest of South & Central America: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 17. Rest of South & Central America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 18. Rest of South & Central America Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 19. Recent Inorganic Growth Strategies in the South & Central America immunodiagnostics market

Table 20. Recent Organic Growth Strategies in the South & Central America immunodiagnostics market

Table 21. Glossary of Terms, South & Central America Immunodiagnostics Market

LIST OF FIGURES

Figure 1. South & Central America Immunodiagnostics Market Segmentation

Figure 2. South & Central America Immunodiagnostics Market, by Country

Figure 3. South & Central America Immunodiagnostics Market Overview

Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in South & Central America Immunodiagnostics Market

Figure 5. Argentina Expected to Show Remarkable Growth During Forecast Period

Figure 6. South & Central America: PEST Analysis

Figure 7. Experts’ Opinion

Figure 8. South & Central America Immunodiagnostics Market: Impact Analysis of Drivers and Restraints

Figure 9. South & Central America Immunodiagnostics Market – Revenue Forecast and Analysis – 2021–2030

Figure 10. South & Central America Immunodiagnostics Market, by Product, 2022 & 2030 (%)

Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 12. Chemiluminescence Immunoassays (CLIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 13. Vitamin D Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 14. HIV Detection: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 15. HIV Ag/Ab Combo Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 16. Other Tests: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 17. Radioimmunoassays (RIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 18. Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 19. South & Central America Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)

Figure 20. Infectious Diseases: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 21. COVID-19: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 22. Tuberculosis: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 23. Lyme: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 24. Infection Management: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 25. Zika: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 26. Treponema: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 27. TORCH: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 28. Measles and Mumps: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 29. VZV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 30. EBV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 31. Hepatitis+HIV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 32. Gastrointestinal: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 33. Metabolics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 34. Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 35. Hypertension: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 36. Growth: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 37. Diabetes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 38. Thyroid: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 39. Reproductive Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 40. Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 41. South & Central America Immunodiagnostics Market Share by End User - 2022 & 2030 (%)

Figure 42. Hospitals: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 43. Clinics: South & Central America Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)

Figure 44. Diagnostic Laboratories: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 45. Academic and Research Institutes: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 46. Others: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 47. South & Central America Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 48. South & Central America: Immunodiagnostics Market, by Country, 2022 & 2030 (%)

Figure 49. Brazil: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 50. Argentina: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 51. Rest of South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 52. Growth Strategies in the South & Central America immunodiagnostics market